✓ Medically reviewed✍️ HairBase editorial team📅 Last updated: June 14, 2026⏱ 1 min read
💡 Quick answer
Moderate evidence. Ketoconazole shampoo reduces scalp inflammation and may have mild anti-DHT effects; studies suggest it supports hair density as an add-on. A useful, low-risk part of a regimen.
As an AliExpress affiliate, we may earn a commission from qualifying purchases.
Evidence: Moderate
Moderate evidence — ketoconazole shampoo calms scalp inflammation and may mildly help density, making it a solid add-on to proven treatments.
Ketoconazole is an antifungal that treats dandruff and seborrhoeic dermatitis, and several studies suggest it also supports hair shaft thickness and density — possibly via anti-inflammatory and mild anti-androgen action on the scalp. It's not a standalone cure for pattern loss, but the evidence for it as a helpful adjunct is better than for most 'natural' options.
Bottom line: a 2% ketoconazole shampoo (prescription) or 1% (over-the-counter) used 2-3 times a week is a low-risk, evidence-supported add-on — especially if you also have flaking or an itchy scalp. Combine it with minoxidil and/or finasteride rather than relying on it alone.
1981Ketoconazole (Janssen) is first approved as an oral antifungal in the US, establishing the imidazole drug whose topical form is later studied for hair loss; its known inhibition of steroidogenesis/androgen synthesis seeds the antiandrogen rationale.
1990FDA approves Nizoral (ketoconazole) 2% shampoo (NDA 019927, Janssen) as a prescription topical for seborrheic dermatitis/dandruff. Its use in androgenetic alopecia has always been off-label, not an FDA-approved hair-loss indication.
1998Piérard-Franchimont et al. publish the first clinical report in Dermatology suggesting 2% ketoconazole shampoo improves hair density and anagen ratio in male AGA comparably to minoxidil, framing scalp Malassezia/inflammation as a contributor.
2002Khandpur et al. (J Dermatol) report a 100-man comparative trial showing ketoconazole as adjunct enhances response, and finasteride-containing regimens outperform monotherapy — cementing ketoconazole's role as an adjunct rather than a stand-alone therapy.
2020Fields et al. publish the first systematic review (Dermatologic Therapy) pooling 7 studies; concludes ketoconazole shampoo shows potential benefit in AGA but evidence is limited, mostly small/low-quality, and best positioned as adjunctive to minoxidil/finasteride.
Key clinical studies
Piérard-Franchimont et al., 19981998
Comparative controlled clinical study in men with grade III vertex AGA (~39 subjects, aged ~21-33); 2% ketoconazole shampoo vs unmedicated shampoo, with/without 2% minoxidil
Hair density, hair shaft diameter, and the proportion of anagen (growing) follicles were improved 'almost similarly' by the 2% ketoconazole and the 2% minoxidil regimens; scalp sebum (casual) level appeared reduced with ketoconazole. Authors explicitly called for larger controlled study, implicating Malassezia-driven inflammation.
Dermatology (Karger), 1998;196(4):474-477
Khandpur et al., 20022002
Open, randomized, parallel-group trial in 100 men with Hamilton grade II-IV AGA; oral finasteride 1 mg/day, topical 2% minoxidil, and 2% ketoconazole shampoo, alone and in combination
Finasteride-containing arms (alone or combined with minoxidil or ketoconazole) showed statistically significant improvement (p<0.05) versus minoxidil alone; combining agents with different mechanisms produced superior results, supporting ketoconazole shampoo as an adjunct. No significant drug-related side effects reported.
The Journal of Dermatology, 2002;29(8):489-498
Fields et al. (Fields, Vonu, Monir, et al.), 20202020
Systematic review (MEDLINE); 47 papers screened, 7 included — 2 murine studies (40 animals) and 5 human studies (318 participants total)
Murine studies showed a significant increase in the mean ratio of hair regrowth to denuded area with ketoconazole vs controls; human studies collectively support potential efficacy of 2% ketoconazole shampoo in AGA. Authors emphasize the evidence base is limited/heterogeneous and recommend ketoconazole as a complementary adjunct to minoxidil and finasteride rather than monotherapy.
Latest research: Recent work (2023-2026) has largely been synthesis and delivery-focused rather than new large RCTs: narrative/clinical reviews (e.g., Gupta et al., 2025) reaffirm 2% ketoconazole shampoo as an evidence-supported adjunct acting via antifungal, anti-inflammatory, and local antiandrogenic (DHT-pathway) effects, while formulation research explores nanostructured lipid carriers and PLGA/ketoconazole nanoparticles to improve scalp/follicular penetration. The consistent caveat is that high-quality, adequately powered head-to-head trials are still lacking.
Summaries reflect published, peer-reviewed research and are not medical advice. See the linked sources for details.
Typically 2-3 times a week, left on the scalp for 3-5 minutes before rinsing. The stronger 2% needs a prescription in many countries; 1% is available over the counter.
Does Nizoral regrow hair?
It's best seen as a supporting treatment that improves scalp health and may help density, not a primary regrowth drug. Use it alongside minoxidil or finasteride for pattern loss.
Not medical advice. General education only; it does not replace diagnosis or treatment by a licensed professional. Consult a board-certified dermatologist before starting, stopping or changing any treatment.